Cytotoxic and antitumor effects of brucine on Ehrlich ascites tumor and human cancer cell line
- 1 August 2011
- journal article
- Published by Elsevier BV in Life Sciences
- Vol. 89 (5-6), 147-158
- https://doi.org/10.1016/j.lfs.2011.05.020
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Vascular endothelial growth factor immunoneutralization in combination with cisplatin reduces EAC tumor growthInternational Immunopharmacology, 2006
- The anti-tumor effects of alkaloids from the seeds of Strychnos nux-vomica on HepG2 cells and its possible mechanismJournal of Ethnopharmacology, 2006
- Vascular Endothelial Growth Factor and AngiogenesisPublished by American Society for Pharmacology & Experimental Therapeutics (ASPET) ,2004
- Intra-tumoural microvessel density in human solid tumoursBritish Journal of Cancer, 2002
- Angiogenesis in cancer and other diseasesNature, 2000
- Tumor Necrosis Factor-α Regulates Expression of Vascular Endothelial Growth Factor Receptor-2 and of Its Co-receptor Neuropilin-1 in Human Vascular Endothelial CellsPublished by Elsevier BV ,1998
- Antiangiogenic tumour therapy: will it work?Trends in Pharmacological Sciences, 1998
- The Biology of Vascular Endothelial Growth FactorEndocrine Reviews, 1997
- The fms -Like Tyrosine Kinase, a Receptor for Vascular Endothelial Growth FactorScience, 1992
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971